Go to content
UR Home

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

Reardon, D. A. ; Dresemann, G. ; Taillibert, S. ; Campone, M. ; van den Bent, M. ; Clement, P. ; Blomquist, E. ; Gordower, L. ; Schultz, H. ; Raizer, J. ; Hau, Peter ; Easaw, J. ; Gil, M. ; Tonn, J. ; Gijtenbeek, A. ; Schlegel, U. ; Bergstrom, P. ; Green, S. ; Weir, A. ; Nikolova, Z.



Abstract

Imatinib in addition to hydroxyurea was well tolerated among patients with recurrent GBM but did not show clinically meaningful anti-tumour activity.


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons